Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Blue Jet Healthcare shares rally 9% after Rs 800 crore QIP allotment
Blue Jet Healthcare shares rose sharply on Friday after the company completed its Rs 800 crore QIP, attracting marquee institutional investors, including multiple ICICI Prudential Mutual Fund schemes. The fund raise is expected to strengthen the company's balance sheet, support expansion plans, and boost long-term growth prospects while broadening its institutional shareholder base.
10 Nifty 500 stocks plunge over 50% from 52-week highs. Do you own any?
Nifty 500 stocks experienced sharp declines, far exceeding index movements. Several companies saw their values drop by over fifty percent from recent highs. Reliance Power and Cohance Lifesciences are among the biggest losers in this market correction.
Chola Securities’ Dharmesh Kant bets on banks, power; cautions on consumer valuations
Dharmesh Kant, Head Research at Chola Securities, says India's growth outlook remains strong, driven by robust demand, infrastructure execution and healthy credit growth. He remains positive on power equipment after further correction, prefers select private and PSU banks, sees value in pharma and hospitals, and is constructive on Mumbai-focused real estate. However, he advises caution on richly valued consumer stocks despite improving business fundamentals.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Take profits near Nifty 24,600; record highs possible by year-end: JM Financial’ Rahul Sharma
Rahul Sharma, Director & Head Technical & Derivatives at JM Financial Services, advises investors to book profits if the Nifty approaches the 24,500–24,600 zone, warning that July earnings could trigger volatility. However, he expects any correction to offer a buying opportunity, with markets likely to begin a structural recovery from September-October and potentially scale fresh record highs by the end of the year. He also remains positive on financials, pharma and select defence stocks.
Kotak Institutional removes ABB India, Siemens, Cummins India from model portfolio
Kotak Institutional Equities' Sanjeev Prasad prefers private banks over IT and expensive industrial stocks, citing attractive valuations, stable credit growth and the potential for re-rating. He warned that AI-driven pricing pressure makes it difficult to value IT companies and said investors should avoid chasing richly valued capital goods and electrification stocks despite strong long-term themes. Healthcare, hospitality, retail and telecom remain among his preferred sectors.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
Welcome To The Jungle Box Office Collection Day 3: Akshay Kumar's Star-Studded Comedy Sees Healthy Response
Welcome To The Jungle opened to a decent response and benefited from its franchise value, star-studded cast and family-friendly appeal.
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve
Laurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing ₹3,000 crore in expanding capacities, particularly for high-value CDMO services, which are projected to double their revenue share by 2030. Analysts are optimistic, raising earnings forecasts and maintaining a 'BUY' rating, anticipating continued growth across its diverse segments.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Stock Market LIVE Updates, Sensex Today: Sensex Jumps 500 Points Higher As Oil Slips To Pre-Iran War Levels - NDTV
Stock Market LIVE Updates, Sensex Today: Sensex Jumps 500 Points Higher As Oil Slips To Pre-Iran War LevelsNDTVSensex Today | Stock Market Live: Nifty at 24,200, Sensex up 550 pts; IndiGo, Max Healthcare, Maruti Suzuki top gainersMoneycontrol.comStock Market Today Live, June 25: Nifty holds above 24,100, Sensex rises 500 pts led by auto, healthcare stocksBusinessLine
RBI expands digital fraud protection, introduces compensation for small-value scam victims
The RBI has expanded customer protection rules for digital payment frauds to cover cases where people are tricked into sending money to scammers and introduced a compensation mechanism for small-value frauds. Eligible victims can receive up to 85% of their losses, subject to a cap of ₹25,000. The rules take effect from January 1, 2027.